Yuan Junhui, Ando Masahiro, Higuchi Itsuro, Sakiyama Yusuke, Matsuura Eiji, Michizono Kumiko, Watanabe Osamu, Nagano Shinjiro, Inamori Yukie, Hashiguchi Akihiro, Higuchi Yujiro, Yoshimura Akiko, Takashima Hiroshi
Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Japan.
Intern Med. 2014;53(14):1563-8. doi: 10.2169/internalmedicine.53.8922. Epub 2014 Jul 15.
Emery-Dreifuss muscular dystrophy (EDMD) is caused by mutations in the EMD gene on the X chromosome, which codes for emerin, an inner nuclear membrane protein. Monoclonal antibodies against the N-terminus of emerin protein are used to screen for emerin deficiency in clinical practice. However, these tests may not accurately reflect the disease in some cases. We herein describe the identification of a splice site mutation in the EMD gene in a Japanese patient who suffered from complete atrioventricular conduction block, mild muscle weakness and joint contracture, and a persistently elevated serum creatine kinase level. We used multiple antibodies to confirm the presence of a novel truncating mutation in emerin without the transmembrane region and C-terminus in the skeletal muscle.
埃默里-德赖富斯肌营养不良症(EDMD)由X染色体上的EMD基因突变引起,该基因编码内核膜蛋白emerin。在临床实践中,针对emerin蛋白N端的单克隆抗体用于筛查emerin缺乏症。然而,在某些情况下,这些检测可能无法准确反映该疾病。我们在此描述了在一名日本患者中鉴定出EMD基因的剪接位点突变,该患者患有完全性房室传导阻滞、轻度肌肉无力和关节挛缩,且血清肌酸激酶水平持续升高。我们使用多种抗体证实了在骨骼肌中存在一种新的emerin截短突变,该突变缺失跨膜区域和C端。